HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ilan Weinreb Selected Research

mucicarmine

1/2012Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity.
5/2010Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ilan Weinreb Research Topics

Disease

49Neoplasms (Cancer)
12/2022 - 08/2006
21Carcinoma (Carcinomatosis)
11/2022 - 12/2009
11Squamous Cell Carcinoma of Head and Neck
01/2022 - 01/2012
8Neoplasm Metastasis (Metastasis)
01/2019 - 12/2009
6Head and Neck Neoplasms (Head and Neck Cancer)
01/2018 - 07/2012
5Oropharyngeal Neoplasms
10/2019 - 04/2012
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2021 - 12/2009
3Mucoepidermoid Carcinoma
09/2021 - 07/2011
3Adenocarcinoma
09/2021 - 06/2016
3Noninfiltrating Intraductal Carcinoma (DCIS)
09/2021 - 07/2013
2Carcinogenesis
12/2022 - 02/2017
2Adenoid Cystic Carcinoma (Cylindroma)
01/2022 - 09/2021
2Salivary Gland Neoplasms (Salivary Gland Cancer)
10/2021 - 11/2018
2Hypertension (High Blood Pressure)
10/2021 - 10/2016
2Hypoxia (Hypoxemia)
10/2021 - 10/2015
2Acinar Cell Carcinoma
09/2021 - 08/2019
2Extranodal Extension
11/2020 - 07/2012
2Nasopharyngeal Carcinoma
01/2020 - 02/2015
2Breast Neoplasms (Breast Cancer)
06/2015 - 07/2013
2Cysts
01/2012 - 09/2011
2Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma)
12/2011 - 09/2009
1Papilloma (Papillomatosis)
12/2021
1Thrombocytopenia (Thrombopenia)
10/2021
1Tonsillar Neoplasms
01/2017
1Hypopharyngeal Neoplasms
11/2016
1Sarcoma (Soft Tissue Sarcoma)
10/2016
1Pleomorphic Adenoma
10/2016
1Diarrhea
10/2016
1Exanthema (Rash)
10/2016
1Epithelioid Hemangioendothelioma
12/2009
1Vascular Neoplasms (Neoplasms, Vascular)
12/2009
1Neuroblastoma
09/2009

Drug/Important Bio-Agent (IBA)

9RNA (Ribonucleic Acid)IBA
11/2022 - 10/2014
9Keratins (Keratin)IBA
12/2021 - 09/2007
6Biomarkers (Surrogate Marker)IBA
10/2021 - 12/2012
6Biological ProductsIBA
10/2021 - 04/2013
5Phenobarbital (Luminal)FDA Link
12/2021 - 12/2009
4Proteins (Proteins, Gene)FDA Link
12/2022 - 12/2014
4CalponinsIBA
12/2021 - 09/2010
4S100 Proteins (S 100 Protein)IBA
03/2021 - 05/2010
4Cisplatin (Platino)FDA LinkGeneric
01/2020 - 10/2016
4Androgen Receptors (Androgen Receptor)IBA
06/2015 - 08/2006
3Immune Checkpoint InhibitorsIBA
10/2021 - 01/2019
3MicroRNAs (MicroRNA)IBA
02/2015 - 12/2009
3MucinsIBA
03/2013 - 03/2009
2Transcription Factors (Transcription Factor)IBA
12/2021 - 12/2014
2Circulating Tumor DNAIBA
10/2021 - 01/2021
2Phosphotransferases (Kinase)IBA
10/2016 - 06/2016
2ChromatinIBA
07/2013 - 09/2007
2High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)IBA
09/2012 - 01/2012
2VimentinIBA
01/2012 - 05/2010
2Periodic AcidIBA
01/2012 - 05/2010
2mucicarmineIBA
01/2012 - 05/2010
2CAM 5.2 antigenIBA
09/2010 - 11/2008
2Mucin-1 (CA 15-3 Antigen)IBA
12/2007 - 07/2007
1Pancreatic Polypeptide (Pancreatic Polypeptide (PP))IBA
12/2021
1Glucagon (Glukagon)FDA Link
12/2021
1Cell-Free Nucleic AcidsIBA
10/2021
1sitravatinibIBA
10/2021
1NivolumabIBA
10/2021
1AS 8IBA
09/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1Coloring Agents (Dyes)IBA
07/2019
1pembrolizumabIBA
01/2019
1Histones (Histone)IBA
02/2017
1Phosphatidylinositol 4,5-Diphosphate (Phosphatidylinositol 4,5 Diphosphate)IBA
10/2016
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
10/2016
1Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
10/2016
1Cetuximab (Erbitux)FDA Link
10/2016
1dacomitinibIBA
10/2016
1ErbB Receptors (EGF Receptor)IBA
10/2016
1CEN-209IBA
10/2015
1Oxidoreductases (Dehydrogenase)IBA
10/2015
1EnzymesIBA
10/2015
1ProdrugsIBA
10/2015
1Tirapazamine (SR 4233)IBA
10/2015
1TH 302IBA
10/2015
1Messenger RNA (mRNA)IBA
12/2014
1IntegrinsIBA
12/2014
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
12/2014
1CortactinIBA
12/2014
1beta CateninIBA
07/2013
1OSM-LIF ReceptorsIBA
07/2013
1Insulin-Like PeptidesIBA
12/2012
1Calbindin 2IBA
12/2011
1ethyl monochloroacetate (EMCA)IBA
07/2011
1Keratin-14 (Keratin 14)IBA
09/2010

Therapy/Procedure

13Radiotherapy
12/2019 - 01/2012
8Therapeutics
01/2020 - 12/2013
7Chemoradiotherapy
01/2021 - 01/2013
5Drug Therapy (Chemotherapy)
01/2022 - 01/2013
4Neck Dissection (Radical Neck Dissection)
01/2022 - 07/2012
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2022 - 01/2019
2Aftercare (After-Treatment)
03/2015 - 08/2011
1Immunotherapy
12/2021
1Drug Tapering
10/2021
1Adjuvant Chemoradiotherapy
11/2020
1Adjuvant Chemotherapy
01/2020
1Precision Medicine
06/2017
1Polypharmacy
01/2017